TITLE

Binding and diffusion characteristics of 14C EDTA and 99mTc DTPA in respiratory tract mucus glycoprotein from patients with chronic bronchitis

AUTHOR(S)
Cheema, M S; Groth, S; Marriott, C
PUB. DATE
September 1988
SOURCE
Thorax;Sep1988, Vol. 43 Issue 9, p669
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66060460

 

Related Articles

  • Hitting the MARCKS. Farley, Suzanne // Nature Reviews Drug Discovery;Feb2004, Vol. 3 Issue 2, p114 

    Focuses on the research of Kenneth Adler and his team into the myristoylated, alanine-rich C-kinase substrate (MARCKS) protein, which is required for secretion of mucin (the glycoprotein component of mucus). Benefits to be derived from inhibiting MARCKS in vivo for patients suffering from...

  • Assessment of non-reperfused and reperfused myocardial infarction using diffusible or deposited radiolabelled perfusion imaging agents. Riou, L. M.; Broisat, A.; Lartizien, C.; Toufektsian, M. C.; Maitrejean, S.; Janier, M.; Vanzetto, G.; Fagret, D.; Ghezzi, C. // European Journal of Nuclear Medicine & Molecular Imaging;Mar2007, Vol. 34 Issue 3, p330 

    Incomplete microvascular reperfusion is often observed in patients undergoing thrombolytic therapy or angioplasty for acute myocardial infarction and has important prognostic implications. We compared the myocardial uptake of diffusible (201Tl) and deposited (99mTcN-NOET) perfusion imaging...

  • Chronic bronchitis: Primary care management. Heath, John M.; Mongia, Rupa // American Family Physician;5/15/1998, Vol. 57 Issue 10, p2365 

    Focuses on optimal management of chronic bronchitis which is one of the main manifestations of chronic obstructive pulmonary disease. How chronic bronchitis is clinically diagnosed; Most effective way to reduce the risk of morbidity from chronic bronchitis; Patients who should be given oral...

  • Loosens mucus.  // Australian Journal of Pharmacy;Jan2014, Vol. 95 Issue 1124, p23 

    The article offers brief information on the Turboforte, device that helps to loosen and remove mucus from the airways from WyMedical Pty. Ltd., by providing positive expiratory pressure therapy for patients suffering with mucus producing respiratory conditions like bronchitis and atelectasis.

  • mecysteine hydrochloride.  // Royal Society of Medicine: Medicines;2002, p348 

    This article presents information on mecysteine hydrochloride or methyl cysteine hydrochloride, a drug used to reduce the viscosity of sputum and so acts as an expectorants in patients with disorders of the upper respiratory tract (eg chronic asthma or bronchitis). Administration is oral.

  • The Role of Infection During Exacerbations of Chronic Bronchitis. Bates, Joseph H. // Annals of Internal Medicine;Jul82, Vol. 97 Issue 1, p130 

    Comments on a study which examined the use of tetracycline in the treatment of acute exacerbations of chronic bronchitis. Definition of an acute exacerbation of chronic bronchitis; Characteristics of bacteria and viruses found on the mucus membranes of the mouth and nasopharynx; Types of...

  • Asthmatic Bronchitis for 2 Years. Starakis, I.; Mylona, M.; Spyropoulos, K.; Dimopoulos, P.A. // Acta Radiologica;Jul2003, Vol. 44 Issue 4, p392 

    Abstract Longstanding asthmatic bronchitis, without evidence of underlying disease, occurring in middle-aged patients, is usually attributed to chronic obstructive pulmonary disease and is treated appropriately. We report a case of 2-year asthmatic bronchitis with recurrent attacks of wheezing,...

  • Domiciliary oxygen in advanced chronic bronchitis.  // British Medical Journal;2/28/1976, Vol. 1 Issue 6008, p484 

    Focuses on the provision of oxygen cylinder measures for house-bound patients with severe respiratory disability from chronic bronchitis. Account on the use of oxygen for chronic diseases; Implication of the measures to the mortality of patients; Usefulness of the oxygen treatment for patients...

  • New advances in assessment of the individual renal function in chronic unilateral renal obstruction using functional CT compared to 99mTc-DTPA renal scan. Elgalil Hamed, Maged Abd // Nuclear Medicine Review;2014, Vol. 17 Issue 2, p59 

    BACKGROUND: The selection of optimal treatment for obstructive nephrouropathy requires information about the functional status of each kidney. Nuclear renal scanning objectively measure differential renal function. Multiple studies have demonstrated the role of CT in assessment of renal...

  • IS SERUM CYSTATIN C (CYS C) A BETTER MARKER OF GLOMERULAR FILTRATION RATE THAN SERUM CREATININE? Talreja, Hari; Sirsat, Rasika; Purl, Vipla; Kothari, Jatin; Almeida, Alan // Indian Journal of Nephrology;Jul-Sep2007, Vol. 17 Issue 3, p104 

    Introduction: Cystatin C is a low molecular weight protein produced by nucleated cells, filtered by the glomeruli and catabolized in the tubules. Studies have claimed its superiority over serum creatinine in estimating GFR. Aims: Compare Cys C with serum creatinine, measured creatinine clearance...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics